Outset Medical
129 hedge funds and large institutions have $2.31B invested in Outset Medical in 2021 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 63 increasing their positions, 13 reducing their positions, and 24 closing their positions.
385% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 13
75% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 24
16% more funds holding
Funds holding: 111 → 129 (+18)
11% more capital invested
Capital invested by funds: $2.09B → $2.31B (+$220M)
0.73% more ownership
Funds ownership: 5.98% → 6.71% (+0.73%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
BlackRock
New York
|
+$148M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$123M |
| 3 |
JP Morgan Chase
New York
|
+$66.6M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$42.7M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$31.1M |
Top Sellers
| 1 |
WP
Warburg Pincus
New York
|
-$198M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$47.9M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$7.11M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$6.16M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$5.44M |
OM Hedge Fund Activity: Q2 2021 in Review
129 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q2 2021, worth a combined $2.31B — up 11% from $2.09B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new OM positions and 24 closed out — a net gain of 18 holders — while 63 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $148M. The largest seller was Warburg Pincus, cutting an estimated $198M.
- 129 institutional investors held Outset Medical (OM) as of Q2 2021, up from 111 in Q1 2021.
- Funds reported $2.31B of Outset Medical stock for Q2 2021, up 11% quarter-over-quarter.
- 42 funds opened new Outset Medical positions in Q2 2021 and 24 closed out, a net change of +18 holders.
- The largest Outset Medical buyer in Q2 2021 was BlackRock, an estimated $148M added.
- The largest Outset Medical seller in Q2 2021 was Warburg Pincus, an estimated $198M sold.
Based on aggregated 13F filings for Q2 2021.